List of Tables
Table 1. Global Anti-tumor Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-tumor Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-tumor Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-tumor Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-tumor Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-tumor Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-tumor Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-tumor Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-tumor Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-tumor Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-tumor Injection, Product Type & Application
Table 12. Global Key Manufacturers of Anti-tumor Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-tumor Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-tumor Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-tumor Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-tumor Injection Sales Market Share by Region (2020-2025)
Table 19. Global Anti-tumor Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-tumor Injection Sales Market Share by Region (2026-2031)
Table 21. Global Anti-tumor Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-tumor Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-tumor Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-tumor Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-tumor Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-tumor Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-tumor Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-tumor Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-tumor Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-tumor Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-tumor Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-tumor Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-tumor Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-tumor Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-tumor Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-tumor Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-tumor Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-tumor Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-tumor Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-tumor Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-tumor Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-tumor Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-tumor Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-tumor Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-tumor Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-tumor Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-tumor Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-tumor Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-tumor Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-tumor Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-tumor Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-tumor Injection Sales Market Share by Type (2020-2025)
Table 53. Global Anti-tumor Injection Sales Market Share by Type (2026-2031)
Table 54. Global Anti-tumor Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-tumor Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-tumor Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-tumor Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-tumor Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anti-tumor Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anti-tumor Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-tumor Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-tumor Injection Sales Market Share by Application (2020-2025)
Table 63. Global Anti-tumor Injection Sales Market Share by Application (2026-2031)
Table 64. Global Anti-tumor Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-tumor Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-tumor Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-tumor Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-tumor Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anti-tumor Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Roche(Genentech) Company Information
Table 71. Roche(Genentech) Description and Business Overview
Table 72. Roche(Genentech) Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche(Genentech) Anti-tumor Injection Product
Table 74. Roche(Genentech) Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Anti-tumor Injection Product
Table 79. Bayer Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Anti-tumor Injection Product
Table 84. Novartis Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Anti-tumor Injection Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Amgen Company Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Amgen Anti-tumor Injection Product
Table 94. Amgen Recent Developments/Updates
Table 95. Mabxience Company Information
Table 96. Mabxience Description and Business Overview
Table 97. Mabxience Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Mabxience Anti-tumor Injection Product
Table 99. Mabxience Recent Developments/Updates
Table 100. Luoxin Pharmaceutical Company Information
Table 101. Luoxin Pharmaceutical Description and Business Overview
Table 102. Luoxin Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Luoxin Pharmaceutical Anti-tumor Injection Product
Table 104. Luoxin Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Qilu Pharmaceutical Anti-tumor Injection Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Company Information
Table 111. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Description and Business Overview
Table 112. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anti-tumor Injection Product
Table 114. Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Recent Developments/Updates
Table 115. Fuxing Medicine Company Information
Table 116. Fuxing Medicine Description and Business Overview
Table 117. Fuxing Medicine Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Fuxing Medicine Anti-tumor Injection Product
Table 119. Fuxing Medicine Recent Developments/Updates
Table 120. Yuekang Pharmaceutical Company Information
Table 121. Yuekang Pharmaceutical Description and Business Overview
Table 122. Yuekang Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Yuekang Pharmaceutical Anti-tumor Injection Product
Table 124. Yuekang Pharmaceutical Recent Developments/Updates
Table 125. Yuheng Pharmaceutical Company Information
Table 126. Yuheng Pharmaceutical Description and Business Overview
Table 127. Yuheng Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Yuheng Pharmaceutical Anti-tumor Injection Product
Table 129. Yuheng Pharmaceutical Recent Developments/Updates
Table 130. Hengrui Medicine Company Information
Table 131. Hengrui Medicine Description and Business Overview
Table 132. Hengrui Medicine Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Hengrui Medicine Anti-tumor Injection Product
Table 134. Hengrui Medicine Recent Developments/Updates
Table 135. Huiyu Pharmaceutical Company Information
Table 136. Huiyu Pharmaceutical Description and Business Overview
Table 137. Huiyu Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Huiyu Pharmaceutical Anti-tumor Injection Product
Table 139. Huiyu Pharmaceutical Recent Developments/Updates
Table 140. Changbaishan Pharmaceutical Co., Ltd. Company Information
Table 141. Changbaishan Pharmaceutical Co., Ltd. Description and Business Overview
Table 142. Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Product
Table 144. Changbaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Innovent Biologics (Suzhou) Co., Ltd. Company Information
Table 146. Innovent Biologics (Suzhou) Co., Ltd. Description and Business Overview
Table 147. Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Product
Table 149. Innovent Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
Table 150. Yifan Pharmaceutical Company Information
Table 151. Yifan Pharmaceutical Description and Business Overview
Table 152. Yifan Pharmaceutical Anti-tumor Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Yifan Pharmaceutical Anti-tumor Injection Product
Table 154. Yifan Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Anti-tumor Injection Distributors List
Table 158. Anti-tumor Injection Customers List
Table 159. Anti-tumor Injection Market Trends
Table 160. Anti-tumor Injection Market Drivers
Table 161. Anti-tumor Injection Market Challenges
Table 162. Anti-tumor Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-tumor Injection
Figure 2. Global Anti-tumor Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-tumor Injection Market Share by Type: 2024 & 2031
Figure 4. Paclitaxel Injection Product Picture
Figure 5. Cisplatin Injection Product Picture
Figure 6. Cyclophosphamide Injection Product Picture
Figure 7. Vincristine Injection Product Picture
Figure 8. Others Product Picture
Figure 9. Global Anti-tumor Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Anti-tumor Injection Market Share by Application: 2024 & 2031
Figure 11. Breast Cancer
Figure 12. Stomach Cancer
Figure 13. Ovarian Cancer
Figure 14. Lung Cancer
Figure 15. Cervical Cancer
Figure 16. Endometrial Cancer
Figure 17. Prostate Cancer
Figure 18. Bladder Cancer
Figure 19. Others
Figure 20. Global Anti-tumor Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Anti-tumor Injection Market Size (2020-2031) & (US$ Million)
Figure 22. Global Anti-tumor Injection Sales (2020-2031) & (K Units)
Figure 23. Global Anti-tumor Injection Average Price (US$/Unit) & (2020-2031)
Figure 24. Anti-tumor Injection Report Years Considered
Figure 25. Anti-tumor Injection Sales Share by Manufacturers in 2024
Figure 26. Global Anti-tumor Injection Revenue Share by Manufacturers in 2024
Figure 27. Global 5 and 10 Largest Anti-tumor Injection Players: Market Share by Revenue in Anti-tumor Injection in 2024
Figure 28. Anti-tumor Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. Global Anti-tumor Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 30. North America Anti-tumor Injection Sales Market Share by Country (2020-2031)
Figure 31. North America Anti-tumor Injection Revenue Market Share by Country (2020-2031)
Figure 32. United States Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Canada Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Europe Anti-tumor Injection Sales Market Share by Country (2020-2031)
Figure 35. Europe Anti-tumor Injection Revenue Market Share by Country (2020-2031)
Figure 36. Germany Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. France Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. U.K. Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Italy Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Russia Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Asia Pacific Anti-tumor Injection Sales Market Share by Region (2020-2031)
Figure 42. Asia Pacific Anti-tumor Injection Revenue Market Share by Region (2020-2031)
Figure 43. China Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Japan Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. South Korea Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. India Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Australia Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. China Taiwan Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Southeast Asia Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Latin America Anti-tumor Injection Sales Market Share by Country (2020-2031)
Figure 51. Latin America Anti-tumor Injection Revenue Market Share by Country (2020-2031)
Figure 52. Mexico Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Brazil Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa Anti-tumor Injection Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Anti-tumor Injection Revenue Market Share by Country (2020-2031)
Figure 57. Turkey Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Saudi Arabia Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. UAE Anti-tumor Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Global Sales Market Share of Anti-tumor Injection by Type (2020-2031)
Figure 61. Global Revenue Market Share of Anti-tumor Injection by Type (2020-2031)
Figure 62. Global Anti-tumor Injection Price (US$/Unit) by Type (2020-2031)
Figure 63. Global Sales Market Share of Anti-tumor Injection by Application (2020-2031)
Figure 64. Global Revenue Market Share of Anti-tumor Injection by Application (2020-2031)
Figure 65. Global Anti-tumor Injection Price (US$/Unit) by Application (2020-2031)
Figure 66. Anti-tumor Injection Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
